1. Clinical Overview of Follistatin-344
Molecule: Follistatin-344 is a 344โamino acid glycoprotein fragment that functions as a potent myostatin (GDF-8) antagonist and broad TGF-ฮฒ family modulator.
Key Roles
- Inhibits myostatin โ powerful muscle growth signaling
- Modulates activin A/B โ tissue repair & regeneration
- Increases muscle fiber size (hypertrophy)
- Enhances fat oxidation & metabolic output
- Supports tendon, ligament, and connective tissue remodeling
Primary Domains of Clinical Use
- Muscle growth & strength enhancement
- Sarcopenia prevention
- Post-injury rehabilitation
- Athletic performance
- Body recomposition
- Metabolic improvement
2. Mechanisms of Action
2.1 Myostatin (GDF-8) Inhibition
Follistatin binds and neutralizes myostatin, which normally suppresses muscle growth. Inhibition results in:
- Increased satellite cell activation
- Accelerated muscle fiber hypertrophy
- Greater lean mass formation
- Enhanced muscle repair after injury
2.2 Activin A/B Blockade
- Reduced inflammation
- Enhanced tissue regeneration
- Greater tendon/ligament healing potential
2.3 Enhanced Satellite Cell Proliferation
- Muscle stem cell (satellite cell) proliferation
- Differentiation of satellite cells into functional fibers
- Faster recovery after mechanical stress, overuse, or injury
2.4 Metabolic Benefits
By increasing muscle mass and improving myocyte function, Follistatin indirectly supports:
- Improved insulin sensitivity
- Higher metabolic rate
- Enhanced fat oxidation
- Better glucose disposal
2.5 Anti-Fibrotic & Regenerative Effects
Follistatin downregulates TGF-ฮฒโdriven fibrosis, supporting muscle healing, liver tissue repair (experimental models), and cardiac fibrosis reduction (preclinical data).
3. Evidence-Based Clinical Applications
3.1 Muscle Growth & Performance
- Increasing lean body mass
- Enhancing strength
- Improving recovery between training sessions
- High-performance athletic protocols
3.2 Sarcopenia & Age-Related Muscle Loss
- Age-related declines in muscle mass
- Muscle frailty
- Functional decline in older adults
3.3 Post-Injury Rehabilitation
Supports recovery in muscle tears, tendon injuries, ligament repair, and rotator cuff recovery programs. Often paired with BPC-157, TB-500, and CJC-1295 / GH secretagogues.
3.4 Metabolic Benefits
- Basal metabolic rate
- Glucose handling
- Fat-free mass preservation during calorie deficits
3.5 Aesthetic / Body Recomposition
- Visibly increased lean mass
- Improved muscle tone
- Decreased body fat percentage
- Enhanced vascularity
4. Administration & Dosing Protocols
4.1 Reconstitution
Add 1 mL bacteriostatic saline โ 1 mg/mL, or 2 mL saline โ 0.5 mg/mL. Gently roll, do not shake!
4.2 Administration Route
- Subcutaneous (SC) โ preferred
- Intramuscular (IM) โ optional for targeted muscle groups
4.3 Standard Dosing Protocols
Performance / Hypertrophy Protocol
Duration: 2โ6 weeks
Rehabilitation Protocol
Often paired with BPC-157, TB-500, CJC-1295
Sarcopenia / Longevity Support
4.4 High-Performance Phase Cycling
Due to potency: short cycles (2โ4 weeks), off periods: 4โ12 weeks.
5. Clinical Decision Trees
Decision Tree 1 โ Is Follistatin-344 Appropriate?
Goal = muscle growth? โ Strong candidate
Goal = post-injury recovery? โ Yes
Goal = metabolic support? โ Moderate candidate
Goal = fat loss only? โ Not first line
Active malignancy / cancer history? โ Avoid (TGF-ฮฒ pathway relevance)
Decision Tree 2 โ Dose Based on Goal
Hypertrophy โ 100โ200 mcg daily
Rehab โ 100 mcg daily
Longevity โ 100 mcg 2โ3ร weekly
Performance โ 250โ500 mcg 2โ3ร weekly
6. Safety, Contraindications & Monitoring
6.1 Contraindications
- Active cancer or recent cancer history (TGF-ฮฒ pathway involvement; potential theoretical risk)
- Pregnancy or breastfeeding
- Uncontrolled metabolic disease
- Hypersensitivity to peptide components
6.2 Potential Side Effects
Generally mild:
- Injection site swelling
- Temporary joint stiffness
- Increased appetite
- Rapid muscle fullness
- Headache
- Fatigue fluctuations
Rare / Dose-Related:
- Possible tendon tightness
- Changes in blood pressure
- Overly rapid hypertrophy โ strain risk
6.3 Monitoring Recommendations
- Body composition
- Strength gains / workout tolerance
- Liver and kidney panels (optional)
- Blood pressure
- Inflammatory markers if high dosing
Legal Disclaimer
The information contained in this document is provided solely for educational and informational purposes for licensed healthcare professionals. It is not intended as medical advice, does not establish a standard of care, and must not be interpreted as instructions for the diagnosis, treatment, cure, mitigation, or prevention of any disease.
Follistatin-344, and other peptides referenced herein are not FDA-approved drugs. Their clinical use may constitute off-label or investigational use. Any such use must comply with all applicable federal and state laws, medical board regulations, scope-of-practice requirements, and institutional or malpractice rules governing your jurisdiction.
Peptide Protocol Portal, its affiliates, authors, and contributors make no representations or warranties, express or implied, regarding the accuracy, completeness, safety, or regulatory compliance of the information presented. Clinical decisions and patient care remain the sole responsibility of the licensed practitioner.
Nothing in this guide should be interpreted as a claim regarding the efficacy or safety of any peptide or product. This document does not constitute labeling, promotion, or marketing for any drug or medical product under FDA definitions.
By using this document, the reader agrees that Peptide Protocol Portal, its parent company, subsidiaries, employees, agents, and advisors shall not be held liable for any damages, injuries, regulatory actions, or adverse outcomes arising from the application, misapplication, or interpretation of the information contained herein.
Use at your own risk. Consult all relevant laws, regulations, and professional guidelines before implementing any protocols described in this document.
References โ Follistatin-344 (1 mg) Clinical Reference Guide
Provider Access Required
Create a provider account to read the full clinical guide for Follistatin-344.